Northwest Biotherapeutics (NWBO) Notes Payables (2010 - 2026)
Northwest Biotherapeutics (NWBO) recorded Notes Payables of $10.25 million in Q2 2026, down 37.2% from $16.31 million a year earlier and down 12.1% from the prior quarter.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Notes Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Northwest Biotherapeutics reported Notes Payables of $9.47 million, down 33.3% from FY2024.
- Annual Notes Payables has a five-year compound annual growth rate of 31.2% (FY2020 to FY2025).
- Across earlier years, Notes Payables came in at $14.19 million in FY2024 (+259.7%), $3.94 million in FY2023 (-74.4%), $15.4 million in FY2022 (+116.8%) and $7.1 million in FY2021 (+191.5%).
- Quarterly Notes Payables has ranged from $3.94 million in Q4 2023 to $20.03 million in Q3 2022 over the past five years.
- On a year-over-year basis, Notes Payables has declined for three consecutive quarters, with growth averaging 45.7% over the last eight quarters.
- Peak year-over-year performance for Notes Payables in the last five years was growth of 435.1% in Q1 2022, against a decline of 74.4% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $11.65 million (Q1 2026), $9.47 million (Q4 2025) and $13.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,168.10 Bn | 1,136.68 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 643.43 Bn | 561.95 Bn | 17.26 Bn |
| 3 | AbbVie | 500.92 Bn | 474.03 Bn | 12.70 Bn |
| 4 | Merck | 360.47 Bn | 314.85 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.41 Bn | 266.40 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.36 Bn | 241.05 Bn | 12.86 Bn |
| 7 | Amgen | 241.30 Bn | 196.70 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 192.97 Bn | 167.17 Bn | 6.22 Bn |
| 9 | Pfizer | 171.65 Bn | 118.30 Bn | 10.94 Bn |
| 10 | Northwest Biotherapeutics | 254.74 Mn | 244.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.25 Mn |
| Mar 31, 2026 | 11.65 Mn |
| Dec 31, 2025 | 9.47 Mn |
| Sep 30, 2025 | 13.57 Mn |
| Jun 30, 2025 | 16.31 Mn |
| Mar 31, 2025 | 19.64 Mn |
| Dec 31, 2024 | 14.19 Mn |
| Sep 30, 2024 | 7.58 Mn |
| Jun 30, 2024 | 8.88 Mn |
| Mar 31, 2024 | 12.13 Mn |
| Dec 31, 2023 | 3.94 Mn |
| Sep 30, 2023 | 8.20 Mn |
| Jun 30, 2023 | 8.40 Mn |
| Mar 31, 2023 | 10.47 Mn |
| Dec 31, 2022 | 15.40 Mn |
| Sep 30, 2022 | 20.03 Mn |
| Jun 30, 2022 | 9.86 Mn |
| Mar 31, 2022 | 11.98 Mn |
| Dec 31, 2021 | 7.10 Mn |
| Sep 30, 2021 | 7.94 Mn |
API Access
Northwest Biotherapeutics Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();